RMD · ResMed
AI read · Good for RMD
The AI's read
That points to continued growth and gives ResMed cash to invest in its business and return money to shareholders. The caution is that the company expects sales growth to slow from 10% this year to 5%–7% next year. Its forecast still shows sales and earnings per share growing, so the results and plans support a positive reading.